Analyst stock forecast
20/20 Biolabs, Inc. Stock Forecast and Analyst Price Target
AIDX analyst target range, upside, consensus rating and coverage count.
Direct answer
20/20 Biolabs, Inc.'s average price target is $5.00.
The target implies +863.4% from the recorded current price, and the consensus rating is none.
The verified range is $5.00 to $5.00, with 1 analysts in the current consensus when available.
Forecast evidence checked August 14, 2026.
Get free 20/20 Biolabs, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.52
- Average price target
- $5.00
- High price target
- $5.00
- Low price target
- $5.00
- Target upside
- +863.4%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 14, 2026
- Valid through
- August 21, 2026